O'Rourke T - Search Results

1

A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days.

Wall JG, Burris HA 3rd, Von Hoff DD, Rodriguez G, Kneuper-Hall R, Shaffer D, O'Rourke T, Brown T, Weiss G, Clark G, et al. Wall JG, et al. Anticancer Drugs. 1992 Aug;3(4):337-45. doi: 10.1097/00001813-199208000-00004. Anticancer Drugs. 1992. PMID: 1330081 Clinical Trial.

2

Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390).

Arteaga CL, Brown TD, Kuhn JG, Shen HS, O'Rourke TJ, Beougher K, Brentzel HJ, Von Hoff DD, Weiss GR. Arteaga CL, et al. Cancer Res. 1989 Aug 15;49(16):4648-53. Cancer Res. 1989. PMID: 2743343

3

Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812).

O'Rourke TJ, Weiss GR, New P, Burris HA 3rd, Rodriguez G, Eckhardt J, Hardy J, Kuhn JG, Fields S, Clark GM, et al. O'Rourke TJ, et al. Anticancer Drugs. 1994 Oct;5(5):520-6. doi: 10.1097/00001813-199410000-00002. Anticancer Drugs. 1994. PMID: 7858283 Clinical Trial.

4

Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies.

Burris HA 3rd, Raymond E, Awada A, Kuhn JG, O'Rourke TJ, Brentzel J, Lynch W, King SY, Brown TD, Von Hoff DD. Burris HA 3rd, et al. Invest New Drugs. 1998;16(1):19-27. doi: 10.1023/a:1016066529642. Invest New Drugs. 1998. PMID: 9740540 Clinical Trial.

5

Testicular relapse in adult acute myelogenous leukemia.

Shaffer DW, Burris HA, O'Rourke TJ. Shaffer DW, et al. Cancer. 1992 Sep 15;70(6):1541-4. doi: 10.1002/1097-0142(19920915)70:6<1541::aid-cncr2820700616>3.0.co;2-6. Cancer. 1992. PMID: 1516005 Review.

6

Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule.

Brown TD, O'Rourke TJ, Kuhn JG, Craig JB, Havlin K, Burris HA 3rd, Cagnola J, Hamilton JM, Grindey GB, Satterlee WG, et al. Brown TD, et al. Anticancer Drugs. 1994 Apr;5(2):151-9. doi: 10.1097/00001813-199404000-00005. Anticancer Drugs. 1994. PMID: 8049498 Clinical Trial.

7

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days.

O'Rourke TJ, Brown TD, Havlin K, Kuhn JG, Craig JB, Burris HA, Satterlee WG, Tarassoff PG, Von Hoff DD. O'Rourke TJ, et al. Eur J Cancer. 1994;30A(3):417-8. doi: 10.1016/0959-8049(94)90276-3. Eur J Cancer. 1994. PMID: 8204374 Clinical Trial. No abstract available.

8

Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.

Von Hoff DD, Fleming TR, Macdonald JS, Goodman PJ, Van Damme J, Brown TD, O'Rourke T, Feun LG, Keppen MD. Von Hoff DD, et al. J Biol Response Mod. 1990 Dec;9(6):584-7. J Biol Response Mod. 1990. PMID: 2127424 Clinical Trial.

9

New anticancer agents.

Weiss GR, Burris HA 3rd, Eckardt JR, Fields S, O'Rourke T, Rodriguez GI, Rothenberg ML. Weiss GR, et al. Cancer Chemother Biol Response Modif. 1994;15:130-51. Cancer Chemother Biol Response Modif. 1994. PMID: 7779583 Review. No abstract available.

10

Improvements in clinical benefit with vinorelbine in the treatment of hormone-refractory prostate cancer: a phase II trial.

Fields-Jones S, Koletsky A, Wilding G, O'Rourke M, O'Rourke T, Eckardt J, Yates B, McGuirt C, Burris HA 3rd. Fields-Jones S, et al. Ann Oncol. 1999 Nov;10(11):1307-10. doi: 10.1023/a:1008315106697. Ann Oncol. 1999. PMID: 10631457 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters